Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, …
| Periodo | 2025-07 | 2025-04 | 2025-01 | 2024-10 |
|---|---|---|---|---|
| Real | — | $-0.60 | $-0.50 | $-0.60 |
| Estimado | $-0.60 | $-0.60 | $-0.70 | $-0.60 |
| Sorpresa | — | +0.0% | +28.6% | +0.0% |
| Métrica | MLEC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 8.4% | 57.4% | -49.0% |
| Operating Margin | -160.8% | -34.4% | -126.4% |
| Net Margin | -130.0% | -32.5% | -97.5% |
| FCF Margin | -168.7% | -12.6% | -156.1% |
| ROE | -107.3% | -39.2% | -68.1% |
| ROA | -21.0% | -30.9% | +9.9% |
| Current Ratio | 1.69 | 2.73 | -1.04 |
| Debt / Equity | — | 0.28 | — |
| Tendencia (Piotroski) | FY24 | FY23 |
|---|---|---|
| ✗Rentabilidad sobre activos positiva | -21.0% | — |
| ✗Flujo de caja operativo positivo | −$9M | −$8M |
| ✓Rentabilidad sobre activos al alza | -21.0% | -215.3% |
| ✗Caja operativa/activos supera al ROA | -26.8% | ROA -21.0% |
| –Menos deuda a largo plazo | — | — |
| ✓Mejor liquidez (ratio corriente) | 1.69 | 0.42 |
| ✗Sin aumentar el nº de acciones | 38M | 34M |
| ✓Margen bruto al alza | 8.4% | -15.8% |
| ✓Rotación de activos al alza | 0.16 | 0.04 |
| Calidad del negocio | FY24 |
|---|---|
| ✗Margen FCF > 10 % | -168.7% |
| ✗ROCE > 10 % | -34.0% |
| ✓Reinversión (I+D + capex) > 3 % de ventas | 34.3% |
Moolec Science SA cotiza a 1.68 USD y tiene una capitalización bursátil de $1M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud